AEFI Under-Reporting Costs
Definition
94% under-reporting by healthcare professionals delays detection of safety issues in complementary medicines, resulting in regulatory interventions, recalls, and compensation costs.
Key Findings
- Financial Impact: 2-5% annual revenue loss from recalls and claims; 20-40 hours/month manual reporting burden
- Frequency: Ongoing due to 94% under-reporting rate
- Root Cause: Voluntary reporting system with barriers; lack of streamlined documentation
Why This Matters
The Pitch: Alternative Medicine players in Australia 🇦🇺 incur 2-5% revenue loss from poor quality signals and recalls due to adverse reaction reporting gaps. Automation captures all events for proactive compliance.
Affected Stakeholders
Practitioners, Clinic Managers, Pharmacovigilance Staff
Deep Analysis (Premium)
Financial Impact
Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.
Current Workarounds
Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.
Get Solutions for This Problem
Full report with actionable solutions
- Solutions for this specific pain
- Solutions for all 15 industry pains
- Where to find first clients
- Pricing & launch costs
Methodology & Sources
Data collected via OSINT from regulatory filings, industry audits, and verified case studies.
Related Business Risks
TGA Non-Reporting Penalties
State AEFI Reporting Fines
Verzögerter Geldeingang bei Selbstzahler-Abonnements
Überhöhte Verwaltungskosten durch manuelle Paket- und Mitgliedsabrechnung
Kundenabwanderung durch intransparente Paket- und Mitgliedsabrechnung
Steuerrisiko und Strafzuschläge durch fehlerhafte Abrechnung von Paketleistungen
Request Deep Analysis
🇦🇺 Be first to access this market's intelligence